A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer
Benoist, G.E., van der Doelen, M.J., ter Heine, R., van Erp, N.P., Mehra, N.Language:
english
Journal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.13532
Date:
January, 2018
File:
PDF, 346 KB
english, 2018